17:16:03 EST Mon 16 Nov 2026
Enter Symbol
or Name
USA
CA



APOTEX HEALTH CORP
Symbol APTX
Shares Issued 229,031,082
Close 2026-11-13 C$ 39.44
Market Cap C$ 9,032,985,874
Recent Sedar+ Documents

ORIGINAL: Apotex to Participate in the Jefferies Global Healthcare Conference in London

2026-11-16 15:30 ET - News Release

Apotex to Participate in the Jefferies Global Healthcare Conference in London

Canada NewsWire

TORONTO, Nov. 16, 2026 /CNW/ -- Apotex Health Corp. ("Apotex") (TSX: APTX) today announced that Jeff Watson, President and CEO, and Brian McClelland, CFO, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, Nov. 18, 2026, at 2:30 p.m. GMT / 9:30 a.m. ET.

Apotex logo

Investors, analysts, members of the media and the general public are invited to view a live webcast of the fireside chat at this weblink. 

About Apotex

Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.

Learn more at www.apotex.com.

SOURCE Apotex Health Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2026/16/c0009.html

Contact:

For investor inquiries, contact ir@apotex.com; For media inquiries, contact media@apotex.com

© 2026 Canjex Publishing Ltd. All rights reserved.